Anti-BRAF (mutated V600E) 抗体 [VE1]
Anti-BRAF (mutated V600E) antibody [VE1]
- BOND RX™ Validated
- Recombinant
- 了解详情
4
(7 Reviews)
|
(129 Publications)
Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) is a mouse monoclonal antibody detecting BRAF in Western Blot, IHC-P. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 110 publications
查看别名
BRAF1, RAFB1, BRAF, Serine/threonine-protein kinase B-raf, Proto-oncogene B-Raf, p94, v-Raf murine sarcoma viral oncogene homolog B1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF (mutated V600E) antibody [VE1] (AB228461)
Immunohistochemical analysis of formalin fixed paraffin embedded human melanoma labelling BRAF (mutated V600E) with ab228461 at 1/600 dilution. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32 mins at 100°C with ULTRA cell conditioning solution (CC1, pH 8.5). ab228461 anti-BRAF (mutated V600E) antibody [VE1] was incubated at 37°C for 16 mins. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF (mutated V600E) antibody [VE1] (AB228461)
Negative control cell line image : IHC image of BRAF (mutated V600E) staining in a section of formalin-fixed paraffin-embedded Caco-2 cell line performed on a Leica BOND™ system using the standard protocol. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab228461, 5ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
This image was generated in-house using a previous batch, manufactured using hybridoma production method.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF (mutated V600E) antibody [VE1] (AB228461)
IHC image of BRAF (mutated V600E) staining in a section of formalin-fixed paraffin-embedded A375 cell line (carrying mutant BRAF V600E) performed on a Leica BOND™ system using the standard protocol. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6 epitope retrieval solution 1) for 20mins. The section was then incubated with ab228461 at 5ug/ml for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
This image was generated in-house using a previous batch manufactured using hybridoma production method.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF (mutated V600E) antibody [VE1] (AB228461)
Immunohistochemical analysis of formalin-fixed paraffin-embedded human melanoma tissue (carrying mutant BRAF V600E) labelling BRAF (mutated V600E) with ab228461 at 1/100 dilution. The section was pre-treated using heat-mediated antigen retrieval method with sodium citrate buffer (pH6 epitope retrieval solution 1) for 20mins. The section was then incubated with ab228461 at 1/100 dilution at room temperature and detected using a Leica BOND™ Polymer refine kit.
- WB
Lab
Western blot - Anti-BRAF (mutated V600E) antibody [VE1] (AB228461)
False colour image of Western blot : Anti-BRAF (mutated V600E) antibody [VE1] staining at 1/1000 dilution, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab228461 was shown to bind specifically to mutant BRAF V600E. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed at 1/20000 dilution.
This image was generated in-house using a previous batch, manufactured using hybridoma production method.
All lanes:
Western blot - Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) at 1/1000 dilution
Lane 1:
HCT 116 cell lysate (wildtype BRAF) at 20 µg
Lane 2:
SW480 cell lysate (wildtype BRAF) at 20 µg
Lane 3:
Caco-2 cell lysate (wildtype BRAF) at 20 µg
Lane 4:
HT-29 cell lysate (mutant BRAF V600E) at 20 µg
Lane 5:
A375 cell lysate (mutant BRAF V600E) at 20 µg
Secondary
Lanes 1 - 5:
Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed at 1/20000 dilution
Lanes 1 - 5:
Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed at 1/20000 dilution
Predicted band size: 84 kDa
Observed band size: 85 kDa,36 kDa
false
不同偶联物与剂型 (1)
-
Anti-BRAF (mutated V600E) antibody [VE1] - BSA and Azide free
反应性数据
产品详情
Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) is a mouse recombinant monoclonal antibody and is validated for use in IHC-P and WB.
Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) was first used in a scientific publication in 2011 and has been cited over 116 times in peer reviewed journals. It's performance in IHC in human and mouse samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) has 6 independent reviews from customers.
Anti-BRAF (mutated V600E) antibody [VE1] (ab228461) specifically detects BRAF Mutated-V600E (UniProt ID: P15056; Molecular weight: 85kDa) and is sold in 100 µL, 500 µL and 1 mL selling sizes.
The BRAF gene helps control cell growth, mutations in BRAF can lead to uncontrolled cell division contributing to cancer. These mutations are common in cancers like melanoma, colon and thyroid, targeted therapies have been developed to treat cancers with BRAF mutations.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
性能和储存信息
形式
纯化工艺
纯化说明
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BRAF plays a central role in the MAPK/ERK signaling pathway which regulates cell cycle progression and apoptosis. It forms a part of a complex with other proteins such as RAS following activation. Mutations in BRAF including the common BRAF V600E result in constitutive activation of the pathway leading to uncontrolled cellular processes. This mutated form alters normal signaling enhancing its oncogenic potential.
Pathways
BRAF integrates into the MAPK/ERK and PI3K/AKT pathways which are essential for proper cellular signaling and function. The MAPK/ERK pathway in particular involves cooperation with proteins like MEK and ERK facilitating cellular responses to growth signals. Variants like BRAF V600K and BRAF V600E significantly impact these pathways by aberrantly activating downstream targets without external stimuli promoting oncogenesis.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (129)
Recent publications for all applications. Explore the full list and refine your search
Nature 647:517-527 PubMed40866703
2025
Applications
Unspecified application
Species
Unspecified reactive species
Virchows Archiv : an international journal of pathology : PubMed40689945
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brain tumor pathology 42:130-142 PubMed40634824
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 6:102183 PubMed40505659
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pathology and translational medicine 59:149-160 PubMed40468609
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:1616 PubMed39794352
2025
Applications
Unspecified application
Species
Unspecified reactive species
Asian Pacific journal of cancer prevention : APJCP 25:2567-2571 PubMed39068592
2024
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 8:147 PubMed39025947
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:3175 PubMed38609408
2024
Applications
Unspecified application
Species
Unspecified reactive species
Genes to cells : devoted to molecular & cellular mechanisms 29:192-206 PubMed38269481
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com